Research Paper Volume 12, Issue 20 pp 20835—20861

SMARCD3 is a potential prognostic marker and therapeutic target in CAFs

Figure 6. (A) IHC staining indicated that SMARCD3 was mainly expressed colon cancer associated fibroblasts. (B) SMARCD3 expression was most associated with fibroblasts by ssGSEA analysis.